← All stories
Markets
Amylyx’s bet on a GLP-1 blocker pays off
A late-stage trial found the drug, which Amylyx bought for cheap in a bankruptcy auction, was effective at regulating blood sugar in patients who’d just undergone bariatric surgery.
Covered by 1 outlet
All coverage · 1 article